About Breath Diagnostics
Breath Diagnostics is a company based in Franklin (United States) founded in 2010 by Victor Van Berkel, Michael Bousamra, Michael H v, and Xiao-An Fu. Breath Diagnostics offers products and services including OneBreath™. Breath Diagnostics operates in a competitive market with competitors including Owlstone Medical, VOCxI Health, Hawkeye Bio, eNose and Astraeus Technologies, among others.
- Headquarter Franklin, United States
- Founders Victor Van Berkel, Michael Bousamra, Michael H v, Xiao-An Fu
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Breath Diagnostics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$225 K (USD), Grant
Dec 15, 2016
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Breath Diagnostics
Breath Diagnostics offers a comprehensive portfolio of products and services, including OneBreath™.
Non-invasive breath analysis for detecting early-stage lung cancer biomarkers.
Funding Insights of Breath Diagnostics
Investors in Breath Diagnostics
Breath Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Breath Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Breath Diagnostics
Investment portfolio details for Breath Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Breath Diagnostics
Detailed financials for Breath Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Breath Diagnostics Comparisons
Peer comparison for Breath Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Breath Diagnostics
Breath Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owlstone Medical, VOCxI Health, Hawkeye Bio, eNose and Astraeus Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Sensor-based platforms for breath diagnostics are developed.
|
|
| Locked | Locked | Locked |
Provider of solution for non-invasive detection of the early stage of lung cancer
|
|
| Locked | Locked | Locked |
Electronic nose technology is developed for medical pathogen detection.
|
|
| Locked | Locked | Locked |
Delivers breath-based point-of-care diagnostics for early cancer detection solutions.
|
Detailed competitors of Breath Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Breath Diagnostics
Complete news archive for Breath Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Breath Diagnostics
Breath Diagnostics was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Breath Diagnostics is headquartered in Franklin, United States.
Ivan Lo is the current CEO of Breath Diagnostics.
Breath Diagnostics was founded in 2010 and is headquartered in Franklin, United States. The company operates in the medical diagnostics sector, focusing on breath analysis technology for lung cancer screening. A system called OneBreath is provided, which employs a patented chemical formulation and micro-reactor to capture and quantify organic compounds from a single breath sample. Early-stage lung cancer detection is enabled through this method.
Breath Diagnostics's top competitors include Owlstone Medical, VOCxI Health and eNose.
Breath Diagnostics offers OneBreath™.
Breath Diagnostics has 1 investor. Key investors include National Science Foundation.